
Opinion|Videos|February 25, 2025
Closing Reflection: A Journey of Understanding and Resilience
Author(s)David Dingli, MD, PhD, Brandi Lewis
Panelists discuss how emerging treatments, digital health tools, and enhanced care coordination could streamline disease management and improve quality of life while identifying opportunities to strengthen provider communication and access to resources.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- How do you think advancements in paroxysmal nocturnal hemoglobinuria care will impact the patient and caregiver experience in the future?
- Are there any aspects of your care or communication with your health care team that you feel could be improved?
This program was made possible with support from Novartis Pharmaceuticals.
Advertisement
Related to this article

In observation of National PA Week, Moffitt PA Mark Honor discusses the expansion of APPs and key collaboration strategies for oncology nurses.

Beth Faiman details the new IMS/IMWG consensus definition of cure for multiple myeloma, requiring 5 years of treatment-free remission.

Oncology clinicians gathered to review relapsed CLL care options, CAR T-cell trial updates, and advanced practice provider roles.

At ASTRO 2026, Suresh Rana details how AI-driven contouring accelerates care timelines, requiring rigorous team monitoring and early nursing input.

At ASTRO 2026, Dr. Erica Braschi Jordan details toxicity tracking, physical therapy referral, and quality of life in proton regional nodal irradiation.

At ASTRO 2026, Dr. Mishaal Munir details how nurse-led triage workflows and prompt symptom escalations improve care for breast cancer brain metastases.

ASTRO 2026 presenter Kayla Kafka-Peterson details an Adapt-Adopt-Build model to bridge global brachytherapy nursing gaps and standardize perioperative care.
Advertisement
Advertisement
Trending on Oncology Nursing News
1
National PA Week: PA-Nurse Synergy Transforms Outpatient Hematology Care
2
Managing Oral and Ocular Toxicities in Metastatic Triple-Negative Breast Cancer
3
FDA Approves Atezolizumab Plus Chemo for Stage 3 dMMR Colon Cancer
4
IMS 2026: Beth Faiman Talks New Definition of Myeloma Cure and More
5

